NantHealth, Inc. (NHIQ) Stock

About NantHealth, Inc.

NantHealth, Inc., together with its affiliates, operates as a health information technology enterprise providing services throughout the United States, Canada, and the United Kingdom. The company offers Eviti, a software-as-a-service (SaaS) clinical decision support tool that centralizes comprehensive clinical data, along with treatment cost details from Medicare reimbursements and information on therapy toxicity. Eviti Connect utilizes this platform to automate pre-authorization procedures, simplifying the complex process of cancer care for both payers and healthcare providers. Physicians can also access the Eviti platform's extensive collection of evidence-based treatment guidelines and protocols via the Eviti Advisor product, aiding them in making informed therapeutic decisions. Furthermore, NantHealth provides NaviNet, a suite of SaaS-based solutions designed to improve communication and integrate information between healthcare payers and providers. This suite includes NaviNet Open, a collaborative platform for health plans and providers, and NaviNet AllPayer, which offers essential eligibility, benefit, and claim status data to provider offices for both commercial and government plans, as well as for Medicare beneficiaries through the Centers for Medicare and Medicaid Services, all accessible via the NaviNet portal. The company also offers OpenNMS, an open-source network monitoring system tailored for enterprise-level networks. Additionally, NantHealth presents Quadris, a data solution that delivers multi-data analysis, detailed reporting, and expert professional services. Founded in 2010, the company, initially known as Nant Health, LLC, changed its name to NantHealth, Inc. in June 2016. Its main office is located in Morrisville, North Carolina. NantHealth, Inc. functions as a subsidiary of NantWorks, LLC.

NantHealth, Inc. is headquartered in US.

NantHealth, Inc. (NHIQ) stock trades at $0.01 with a market capitalization of $329656. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.05, and currently trades 80.0% below its 52-week high.

On profitability, NantHealth, Inc. generates a return on equity (ROE) of 34.99% — well above the market average, a sign of a high-quality business, return on capital employed of -41.42%, an operating margin of -76.61%, a net profit margin of -101.16%.

Official website: nanthealth.com